This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1991 Apr 3;83(7):462-3.

doi: 10.1093/jnci/83.7.464.

Chemoprevention for breast cancer: are we ready?

PMID: 2005624
DOI: 10.1093/jnci/83.7.464

Editorial

Chemoprevention for breast cancer: are we ready?

D T Kiang. J Natl Cancer Inst. 1991.

. 1991 Apr 3;83(7):462-3.

doi: 10.1093/jnci/83.7.464.

Author

PMID: 2005624
DOI: 10.1093/jnci/83.7.464

No abstract available

PubMed Disclaimer

Similar articles

Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.
Jordan VC. Jordan VC. Cancer Invest. 1988;6(5):589-95. doi: 10.3109/07357908809082124. Cancer Invest. 1988. PMID: 3063338 Review. No abstract available.
Antiestrogens as chemopreventive agents in breast cancer: promise and issues in evaluation.
Love RR. Love RR. Prev Med. 1989 Sep;18(5):661-71. doi: 10.1016/0091-7435(89)90037-6. Prev Med. 1989. PMID: 2694160 Review.
Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention.
Jordan VC. Jordan VC. Cancer Treat Rev. 1990 Mar;17(1):15-36. doi: 10.1016/0305-7372(90)90074-p. Cancer Treat Rev. 1990. PMID: 2224868 Review. No abstract available.
Intralesional human chorionic gonadotropin for Kaposi's sarcoma.
Russo IH. Russo IH. N Engl J Med. 1997 Apr 17;336(16):1187; author reply 1188-9. N Engl J Med. 1997. PMID: 9102574 No abstract available.
Tamoxifen for the prevention of breast cancer: yes.
Vogel VG, Saenz M. Vogel VG, et al. Important Adv Oncol. 1995:187-200. Important Adv Oncol. 1995. PMID: 7672805 Review. No abstract available.

See all similar articles

Cited by

Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.
Dhingra K, Sahin A, Supak J, Kim SY, Hortobagyi G, Hittelman WN. Dhingra K, et al. Breast Cancer Res Treat. 1992;23(3):201-10. doi: 10.1007/BF01833516. Breast Cancer Res Treat. 1992. PMID: 1463859
An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.
Lehrer SP, Schmutzler RK, Rabin JM, Schachter BS. Lehrer SP, et al. Breast Cancer Res Treat. 1993;26(2):175-80. doi: 10.1007/BF00689690. Breast Cancer Res Treat. 1993. PMID: 8219254
Mechanisms of hormone resistance in breast cancer.
Horwitz KB. Horwitz KB. Breast Cancer Res Treat. 1993;26(2):119-30. doi: 10.1007/BF00689685. Breast Cancer Res Treat. 1993. PMID: 8219249 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information